Agarwal Arjun bought ORKA
June 12, 2026 · Form 4 insider transaction
Agarwal Arjun bought 8,000 shares of Oruka Therapeutics, Inc. at $12.50 per share, a transaction worth $100.0K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Acquired (buy-side)
Shares
8,000
Price
$12.50
Total value
$100.0K
InsiderAgarwal Arjun
Role—
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 12, 2026
Filing dateJune 15, 2026
Shares owned after25,294
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Includes 888 shares acquired under the Oruka Therapeutics, Inc. stock purchase plan on June 8, 2026.